Upregulation of Monocyte Urokinase Plasminogen Activator Receptor during Human Endotoxemia
Open Access
- 1 April 2000
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (4) , 2156-2160
- https://doi.org/10.1128/iai.68.4.2156-2160.2000
Abstract
The receptor for urokinase-type plasminogen activator (uPAR) (CD87) plays an important role in leukocyte adhesion and migration. To assess the effect of endotoxin on cellular uPAR, uPAR expression was determined on leukocytes by fluorescence-activated cell sorter analysis in seven healthy subjects following intravenous injection of endotoxin (lot G; 4 ng/kg). Endotoxin induced a transient increase in uPAR expression on monocytes, reaching a 92% ± 46% increase over baseline expression after 6 h (P< 0.05). Endotoxin did not influence uPAR expression on granulocytes, while uPAR remained undetectable on lymphocytes. Endotoxin also increased soluble uPAR levels in plasma (P< 0.05). Stimulation of human whole blood with endotoxin or gram-positive stimuli in vitro also resulted in an upregulation of monocyte uPAR expression. Although tumor necrosis factor alpha (TNF) upregulated monocyte uPAR expression, anti-TNF did not influence the endotoxin-induced increase in monocyte uPAR expression. These data suggest that infectious stimuli may influence monocyte function in vivo by enhancing the expression of uPAR.Keywords
This publication has 45 references indexed in Scilit:
- uPA, uPAR, PAI-I: Key intersection of proteolytic, adhesive and chemotacfic highways?Immunology Today, 1997
- Regulation of Integrin Function by the Urokinase ReceptorScience, 1996
- The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes.Journal of Clinical Investigation, 1996
- Human urokinase receptor expression is inhibited by amiloride and induced by tumor necrosis factor and phorbol ester in colon cancer cellsFEBS Letters, 1994
- The urokinase receptor is required for human monocyte chemotaxis in vitro.Journal of Clinical Investigation, 1994
- A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.Journal of Clinical Investigation, 1993
- Monoclonal antibodies to human tumor necrosis factor α: In vitro and in vivo applicationCytokine, 1990
- Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.The Journal of Experimental Medicine, 1989
- Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature, 1987
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985